Johnson & Johnson CFO taps internal investment for medtech growth
The pharma company is on track to reach $100 billion in recorded revenue despite “temporary” headwinds in its medtech segment, executives said.
We haven't written up this one. CFO Dive has the full story — the link below goes straight to it.